A Phase 2, Randomized, Partially Blinded, Active-Controlled Study Assessing the Efficacy and Safety of Variable Anticoagulation Reversal Using the REG1 System in Patients With Acute Coronary Syndromes: Results of the RADAR Trial

Study Questions:

What is the feasibility of using pegnivacogin to prevent ischemic events and the degree of anticoagulation reversal required to mitigate bleeding in acute coronary syndrome (ACS) patients managed with an early invasive approach?